Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sample Collection to Facilitate the Performance Evaluation of the LumiraDx Point of Care Device for the Detection of Influenza A/B, Respiratory Syncytial Virus (RSV) & COVID-19 (SARS-COV-2 Virus)

NCT04782336 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.

NCT NCT04782336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04782336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sample Collection to Facilitate the Performance Evaluation of the LumiraDx Point of Care Device for the Detection of Influenza A/B, Respiratory Syncytial Virus (RSV) & COVID-19 (SARS-COV-2 Virus)
Lead sponsor
LumiraDx UK Limited
Phase
Observational
Overall status
Completed
Start date
June 30, 2021
Completion date
August 10, 2021
Enrollment
79 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, influenza type a, influenza type b, rsv infection